Verbindungskombinationen mit dokumentierter mechanistischer Begründung
Synergistic tissue repair — BPC-157 targets gut and tendon via NO, GHR, and fibroblast signaling; TB-500 (Thymosin beta-4 heptapeptide fragment) is studied for systemic actin remodeling and angiogenesis. Research suggests complementary mechanisms with non-overlapping targets.
Begründung →Skin-focused combination — GHK-Cu stimulates collagen and antioxidant pathways; BPC-157 supports wound healing and tissue repair. Often explored for skin rejuvenation in anecdotal literature.
Begründung →CJC-1295 (GHRH analogue) and Ipamorelin (GHRP/ghrelin agonist) act on different points of the GH axis, producing synergistic pulsatile GH release while minimizing cortisol/prolactin side effects associated with older GHRPs.
Begründung →Complementary cognitive optimization — Selank modulates anxiety and neuroinflammation via GABAergic and enkephalinase-inhibitory pathways; Semax promotes neuroplasticity through BDNF/TrkB activation and neurotransmitter modulation. Research suggests largely non-overlapping mechanisms targeting both the stress-cognition interface and direct cognitive enhancement.
Begründung →MOTS-c (mitochondrial-derived peptide) activates AMPK signaling and improves insulin sensitivity via nuclear gene regulation. AOD-9604 (hGH fragment 177-191) stimulates lipolysis through β3-adrenergic receptors and inhibits lipogenesis without elevating IGF-1. Two complementary, non-overlapping metabolic pathways — insulin/glucose regulation paired with targeted fat mobilization.
Begründung →Dual-pathway GH optimization — Tesamorelin (GHRH agonist) drives GH synthesis and visceral fat reduction via the GHRH receptor/cAMP axis; Ipamorelin (selective ghrelin mimetic) amplifies GH pulse amplitude via GHSR-1a without raising cortisol or prolactin. Research suggests complementary, non-overlapping mechanisms that may produce additive GH release when combined.
Begründung →Cellular longevity and structural repair — Epitalon activates telomerase and elongates telomeres at the chromosomal level; GHK-Cu drives copper-dependent tissue remodeling, collagen synthesis, and antioxidant gene expression. Telomere maintenance + extracellular matrix renewal.
Begründung →Dual-pathway GH stimulation — Sermorelin (GHRH analogue, physiological pulsatile GH release) + Ipamorelin (ghrelin mimetic, selective GH release without cortisol/prolactin). Complementary receptor targets producing additive GH secretion.
Begründung →Local tissue repair meets systemic growth support — BPC-157 targets damaged tissue via mTOR, VEGF, and NO pathways for direct cellular repair; Sermorelin stimulates endogenous GH release through GHRH receptors for systemic recovery and regeneration. Local and systemic mechanisms operating at different biological scales.
Begründung →Complementary gut-focused mechanisms — BPC-157 targets tissue repair via mTOR, VEGF, and NO system for barrier restoration; KPV suppresses NF-κB and inflammatory signaling via PepT1-mediated nuclear uptake. Local anti-inflammatory + structural repair without pathway overlap.
Begründung →Three compounds targeting distinct hallmarks of aging through non-overlapping mechanisms — Epithalon for telomerase activation and circadian melatonin restoration, GHK-Cu for extracellular matrix remodeling and antioxidant gene regulation, NAD+ for sirtuin-mediated metabolic homeostasis, PARP-dependent DNA repair, and mitochondrial bioenergetics. Research suggests each addresses a different axis of cellular senescence, making the combination mechanistically complementary rather than redundant.
Begründung →Triple-mechanism sleep optimization — Epitalon restores pineal melatonin production via MT1 receptor interaction; Selank reduces sleep-disrupting anxiety through GABAergic modulation and enkephalinase inhibition; Sermorelin enhances deep slow-wave sleep by amplifying endogenous GH pulsatility. Research suggests complementary pathways targeting circadian rhythm, stress response, and sleep architecture.
Begründung →Dual-pathway longevity approach — MOTS-c targets mitochondrial metabolism and stress adaptation via AMPK/PGC-1α; Epitalon activates telomerase and supports circadian rhythm restoration. Addresses two distinct hallmarks of aging: metabolic decline and telomere attrition.
Begründung →Weitere Stacks — einschließlich Bioregulator- und Nootropik-Kombinationen — folgen in Kürze.